Newly diagnosed patients with cancer at increased risk for stroke
the ONA take:
According to a new study published in the journal Annals of Neurology, researchers at Weill Cornell Medical College in New York City, New York, have found that newly diagnosed patients with cancer, particularly those with more aggressive disease, are at an increased risk for stroke in the months following diagnosis.
For the study, researchers analzyed Medicare claims from 2001 to 2009 by patients who had been diagnosed with colorectal, prostate, breast, lung, and pancreatic cancer. Results showed that compared to seniors without cancer, those with cancer had a much risk for stroke, especially during the first 3 months following cancer diagnosis.
Patients with colorectal, lung, and pancreatic cancer had the highest risk of stroke, as those diseases are often more aggressive at the time of diagnosis. Those with breast and prostate cancer had the lowest risk for stroke as those diseases are typically diagnosed as localized tumors.
Although the study was not designed to determine why patients with cancer have an increased risk for stroke, the researchers suggest that cancer and the treatments for cancer affect the circulatory and coagulation systems. The researchers note that patients should be advised of the signs and symptoms of stroke as it can delay cancer treatment and cause disability and death.
Newly diagnosed patients with cancer are at an increased risk for stroke in the months following diagnosis.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|